- Report
- October 2025
- 187 Pages
Global
From €3186EUR$3,545USD£2,794GBP
€3540EUR$3,939USD£3,105GBP
- Report
- October 2025
- 180 Pages
Global
From €3186EUR$3,545USD£2,794GBP
€3540EUR$3,939USD£3,105GBP
- Report
- August 2025
- 189 Pages
Global
From €3186EUR$3,545USD£2,794GBP
€3540EUR$3,939USD£3,105GBP
- Report
- October 2025
- 250 Pages
Global
From €4036EUR$4,490USD£3,539GBP
- Report
- March 2025
- 200 Pages
Global
From €4036EUR$4,490USD£3,539GBP
- Report
- April 2025
- 198 Pages
Global
From €4490EUR$4,995USD£3,937GBP
- Report
- June 2025
- 98 Pages
Europe
From €3550EUR$3,950USD£3,114GBP
- Report
- November 2018
- 156 Pages
Global
From €3145EUR$3,499USD£2,758GBP
- Book
- December 2022
- 360 Pages
The Genomic Data Sharing market is a rapidly growing sector of the genomics industry. It involves the sharing of genomic data between organizations, such as research institutions, pharmaceutical companies, and healthcare providers. This data is used to develop new treatments and therapies, as well as to improve existing ones. It also helps to identify new genetic markers and to better understand the genetic basis of diseases.
The Genomic Data Sharing market is driven by the increasing demand for personalized medicine, as well as the need for more accurate and comprehensive data. This data is used to develop new treatments and therapies, as well as to improve existing ones. It also helps to identify new genetic markers and to better understand the genetic basis of diseases.
Some companies in the Genomic Data Sharing market include Illumina, 23andMe, Genomics England, and Helix. Show Less Read more
